Coegin Pharma AB (NGM:COEGIN)
Sweden · Delayed Price · Currency is SEK 4.100
-0.140 (-3.30%)
At close: Jan 7, 2026
Coegin Pharma AB Market Cap
Coegin Pharma AB has a market cap or net worth of 106.72 million as of January 9, 2026. Its market cap has increased by 32.20% in one year.
Market Cap
106.72M
Enterprise Value
99.35M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.10
Market Cap Chart
Since May 7, 2021, Coegin Pharma AB's market cap has decreased from 148.38M to 106.72M, a decrease of -28.08%. That is a compound annual growth rate of -6.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 106.48M | -3.60% |
| Dec 30, 2025 | 110.46M | 40.73% |
| Dec 30, 2024 | 78.49M | 55.23% |
| Dec 29, 2023 | 50.56M | -47.61% |
| Dec 30, 2022 | 96.51M | -57.65% |
| Dec 30, 2021 | 227.88M | 53.58% |
| May 7, 2021 | 148.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Investor AB | 1.04T |
| Atlas Copco AB | 835.72B |
| AB Volvo | 628.81B |
| EQT AB | 422.38B |
| ASSA ABLOY AB | 405.10B |
| Sandvik AB | 395.63B |
| Skandinaviska Enskilda Banken AB | 391.06B |
| Swedbank AB | 368.30B |